India · Delayed Price · Currency is INR Global Health Statistics
Total Valuation
Global Health has a market cap or net worth of INR 338.27 billion. The enterprise value is 339.09 billion.
| Market Cap | 338.27B |
| Enterprise Value | 339.09B |
Important Dates
The next estimated earnings date is Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Global Health has 268.85 million shares outstanding. The number of shares has increased by 0.27% in one year.
| Current Share Class | 268.85M |
| Shares Outstanding | 268.85M |
| Shares Change (YoY) | +0.27% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 44.27% |
| Owned by Institutions (%) | 21.06% |
| Float | 87.23M |
Valuation Ratios
The trailing PE ratio is 60.90 and the forward PE ratio is 48.59. Global Health's PEG ratio is 2.38.
| PE Ratio | 60.90 |
| Forward PE | 48.59 |
| PS Ratio | 7.67 |
| PB Ratio | 8.49 |
| P/TBV Ratio | 8.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 47.35 |
| PEG Ratio | 2.38 |
Enterprise Valuation
| EV / Earnings | 60.94 |
| EV / Sales | 7.69 |
| EV / EBITDA | 36.89 |
| EV / EBIT | 48.68 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.30.
| Current Ratio | 2.67 |
| Quick Ratio | 2.46 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 1.29 |
| Debt / FCF | -9.61 |
| Interest Coverage | 8.80 |
Financial Efficiency
Return on equity (ROE) is 15.03% and return on invested capital (ROIC) is 14.43%.
| Return on Equity (ROE) | 15.03% |
| Return on Assets (ROA) | 8.16% |
| Return on Invested Capital (ROIC) | 14.43% |
| Return on Capital Employed (ROCE) | 13.20% |
| Weighted Average Cost of Capital (WACC) | 5.27% |
| Revenue Per Employee | 4.30M |
| Profits Per Employee | 542,359 |
| Employee Count | 10,260 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 28.65 |
Taxes
In the past 12 months, Global Health has paid 1.61 billion in taxes.
| Income Tax | 1.61B |
| Effective Tax Rate | 22.51% |
Stock Price Statistics
The stock price has increased by +8.07% in the last 52 weeks. The beta is 0.19, so Global Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +8.07% |
| 50-Day Moving Average | 1,181.32 |
| 200-Day Moving Average | 1,199.98 |
| Relative Strength Index (RSI) | 62.22 |
| Average Volume (20 Days) | 231,365 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Global Health had revenue of INR 44.10 billion and earned 5.56 billion in profits. Earnings per share was 20.66.
| Revenue | 44.10B |
| Gross Profit | 23.17B |
| Operating Income | 6.97B |
| Pretax Income | 7.15B |
| Net Income | 5.56B |
| EBITDA | 9.19B |
| EBIT | 6.97B |
| Earnings Per Share (EPS) | 20.66 |
Balance Sheet
The company has 11.30 billion in cash and 11.90 billion in debt, with a net cash position of -598.18 million or -2.22 per share.
| Cash & Cash Equivalents | 11.30B |
| Total Debt | 11.90B |
| Net Cash | -598.18M |
| Net Cash Per Share | -2.22 |
| Equity (Book Value) | 39.84B |
| Book Value Per Share | 147.47 |
| Working Capital | 10.48B |
Cash Flow
In the last 12 months, operating cash flow was 7.14 billion and capital expenditures -8.38 billion, giving a free cash flow of -1.24 billion.
| Operating Cash Flow | 7.14B |
| Capital Expenditures | -8.38B |
| Depreciation & Amortization | 2.23B |
| Net Borrowing | 3.44B |
| Free Cash Flow | -1.24B |
| FCF Per Share | -4.60 |
Margins
Gross margin is 52.54%, with operating and profit margins of 15.79% and 12.62%.
| Gross Margin | 52.54% |
| Operating Margin | 15.79% |
| Pretax Margin | 16.21% |
| Profit Margin | 12.62% |
| EBITDA Margin | 20.84% |
| EBIT Margin | 15.79% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.04%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.04% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 2.42% |
| Buyback Yield | -0.27% |
| Shareholder Yield | -0.23% |
| Earnings Yield | 1.65% |
| FCF Yield | -0.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Global Health is 1,419.06, which is 12.11% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 1,419.06 |
| Price Target Difference | 12.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 16.06% |
| EPS Growth Forecast (3Y) | 22.24% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |